We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
on
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
off
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
off
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
on
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active

Gx/BGx Manufacturer—Commercial Due Diligence

Task:
Assess investment risks and provide an independent opinion on Target's core business areas.
Task:
Assess investment risks and provide an independent opinion on Target's core business areas.
Client:
EBRD
Region:
Ukraine, CIS, export markets
Organization:
  • Assess the adequacy of Target’s management resources (both extent and quality).
  • Assess the organizational structure and decision-making process within Target.
  • Assess the quality of Target’s IT, finance, and operational systems for managing Target and reporting on its operational and financial performance.
Deliverables:
  • An independent assessment of the investment project.
  • Revision of the information provided by the Target and the Client.
  • In-depth research of the core Target's pharmaceutical market.
  • A set of interviews with Target's top management with insights and recommendations.
Investment program:
  • assess the Project Cost, including construction and equipment costs and Project Financing Plan;
  • assess the appropriateness of technology and equipment suggested by Target, including sources of such technology/equipment and reasonableness of indicative costs;
  • review equipment procurement process and draft contracts with key equipment suppliers;
  • review draft contract with the main contractor(s) for the construction works;
  • assess the lead time for the key components of the Investment Programme;
  • verify contingency plans to cover shortfalls;
  • provide an assessment of the proposed time-line of new manufacturing capacity becoming operational;
  • assess the GMP certification process of Target’s new production facilities;
  • review the recent project preparation/implementation status.
Product portfolio:
  • provide a detailed review of Target’s current and planned products (including within its core markets), pricing, margins, and outlook;
  • original and generic products driving Target’s sales;
  • assessment of Target’s new product development process and in-house research and development (R&D) capacity to develop new original and generic products;
  • assessment of Target’s ability to continue replacing non-target's originals (following patent expiring and availability for a copy) with new generic products.
Competitive position:
  • assess  existing and planned customer base (customer profile), including hospital segment;
  • assess customer contracts, their length, volume/price guarantees, termination clauses, and raw-material cost pass-through ability;
  • identify the main raw materials and operating costs of the Company, and the main suppliers of these products/services plus any available alternatives;
  • identify whether any major contracts are priced below or above market levels;
  • analyze inter-company goods and cash flows (including the Company’s existing raw materials supply chains involving off-shore companies) as well as transfer pricing practices and tax arrangements used by the Company;
  • analyze cost/price competitiveness of the Company and its ability to maintain it in the future;
  • assess distribution channels: effectiveness of proposed channels, trends, key players, and cost justification;
  • analyze indigenous and foreign competitors and their respective market shares;
  • produce a SWOT analysis;
  • comment on existing production facilities, the performance of the existing equipment, utilization rate.
Industry regulation:
  • Review the current and prospective market regulation affecting Target’s operations, including:
  • licensing: to confirm availability and validity of Target’s timeless licenses issued by the Ministry of Health also confirming the Target’s compliance with GDP standards; procedures for the confirmation of the license validity by the Ministry of Health;
  • product certification/registration process (e.g., regulatory approvals needed, timing for bringing products to market, potential regulatory hurdles, and risks to commercialization of the newly planned products);
  • regulation of prices of medicine producers;
  • raw materials import taxes and duties;
  • supply to state hospitals: key requirements, procedures, contracts, promotion, payment terms, etc.);
  • introduction of mandatory medical insurance and reimbursement mechanism;
  • the potential of introduction of VAT on medicines and ban on medicine advertising;
  • any other regulatory risks.
Key areas covered in the project:
  • Assessment of Target’s strategy, investment program, and business plan.
  • Understanding the sustainability of Target’s competitiveness and profitability.
  • Study of the industry regulation.
  • Analysis of the intercompany goods and cash flows of the Target
  • Assess transfer pricing and tax arrangements of Target.
  • Study of the quality of the management team, organizational structure, and systems.
Market study:

To perform Ukrainian Target's core markets analysis:

  • evaluate Target’s marketing strategy for its core market, including product mix, pricing policy, logistic and distribution’s channels, advertising/promotion;
  • provide recommendations on marketing strategy improvement;
  • assess market volume (i.e., size in volume, value terms, and contribution’s margin), market growth rate (i.e., growth trends and assumptions for the period of up to 5 years), key players and their market shares, supply and demand, long-term trends, product substitution, the Target’s existing and potential market share.
  • review and  confirm whether existing marketing and sales structure and workforces are  appropriate


Project
leads

Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
Anastasiia Maksymenko
Co-founder, Recruitment Partner (Pharma, Biotechnology, MedTech, Healthcare)
Download
our Brochure